CLB EBITDA Growth
Core Laboratories Inc · EBITDA Growth
CLB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-8.42%period ending
CLB TTM EBITDA YoY % (-58.66% → -8.42%)
Year-over-year change
High-resolution chart · PNG
CLB ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -8.424% | |
| -0.8595% | |
| -3.254% | |
| -6.7004% | |
| -1.6574% | |
| -3.9193% | |
| 4.7674% | |
| 4.7269% | |
| -2.4306% | |
| 8.8907% | |
| 17.3095% | |
| 23.3823% | |
| 45.5655% | |
| 38.0469% | |
| -0.7451% | |
| -5.9887% | |
| -27.5369% | |
| -11.823% | |
| 191.7688% | |
| 206.4127% | |
| 281.7994% | |
| 970.5958% | |
| -155.047% | |
| -149.4759% | |
| -130.9697% | |
| -104.9723% | |
| -12.2171% | |
| -22.7567% | |
| -16.4546% | |
| -10.3605% | |
| -1.0839% | |
| 18.6947% | |
| 18.1717% | |
| 24.1162% | |
| 21.5204% | |
| 9.7571% | |
| -13.8718% | |
| -33.2253% | |
| -40.0346% | |
| -54.6719% | |
| -52.5299% | |
| -49.2476% | |
| -49.4873% | |
| -31.1287% | |
| -18.7168% | |
| -8.3234% | |
| 3.9948% | |
| 7.1712% | |
| 8.8296% | |
| 13.3458% | |
| 16.0116% | |
| 12.7302% | |
| 14.3139% | |
| 12.3062% | |
| 13.24% | |
| 17.1106% | |
| 14.0159% | |
| 14.9449% | |
| 12.0758% | |
| 15.2596% | |
| 25.1942% | |
| 21.6975% | |
| 25.9889% | |
| 14.8472% | |
| -1.2721% | |
| -6.1507% | |
| -12.2107% | |
| -13.7177% | |
| -5.2095% | |
| 7.7767% | |
| 16.7186% | |
| 37.9441% | |
| 42.925% | |
| 36.818% | |
| 39.7659% | |
| 45.109% | |
| 62.339% | |
| 94.5331% | |
| 106.4884% | |
| 79.5773% | |
| 41.6159% | |
| 18.6145% | |
| 2.0576% | |
| 0.0722% | |
| 5.6725% | |
| 1.3869% | |
| 12.4531% | |
| 54.5574% | |
| 72.7444% | |
| 74.4415% | |
| 44.8507% | |
| -6.3896% | |
| -29.3465% | |
| -36.9601% | |
| -36.657% | |
| -38.2641% | |
| -20.8437% | |
| -4.9905% | |
| 14.6289% | |
| 34.5437% |